Molecular methods of detection based on DNA-sequencing of the internal transcribed spacer 1 and 2 (ITS1 and ITS2) or 5 end region of 28S (D1-D2 region) of ribosomal RNA gene (rDNA) have been used extensively for molecular identification and detection of fungal infections. However, these regions are not always informative for identification of mucormycetes and other rare fungal pathogens as they often contain large introns, heterogenic regions, and/or cannot be PCR-amplified using broad range fungal PCR primers. In addition, because of the difficulties of recovering intact fungal DNA from human specimens, smaller regions of DNA are more useful for the direct detection of fungal DNA in tissues and fluids. In this study, we investigated the utility of 12F/13R PCR primers targeting a 200-230 bp region of the extended 28S region of rDNA for molecular identification of fungal DNA in formalin fixed paraffin embedded tissues and other clinical specimens. We demonstrated that this region can be successfully used for identification of all genera and some species of clinically relevant mucormycetes, as well as other medically important fungi, such as Aspergillus, Fusarium, Coccidioides, and Cryptococcus. We also demonstrated that PCR amplification and direct sequencing of the extended 28S region of rDNA was more sensitive compared to targeting the ITS2 region, as we were able to detect and identify mucormycetes and other fungal pathogens in tissues from patients with histopathological and/or culture evidence of fungal infections that were negative with PCR using ITS-specific primers.
Introduction
Mucormycetes are widespread in the environment and can cause severe infections in people with impaired immune systems, such as patients with human immunodeficiency virus (HIV), organ transplants, hematologic malignancies, diabetes mellitus, renal failure, and others. 1 Mucormycetes can also infect people with healthy immune systems who underwent subcutaneous traumatic inoculation of large amounts of soil and debris, such as the victims of a tornado in Joplin, Missouri. 1, 2 Timely and accurate diagnostics of mucormycetes is essential since these infections progress rapidly and often require a different and/or more aggressive treatment compared to other fungi. Molecular methods of detection have been successfully used in diagnostics of fungal infections caused by mucormycetes and other fungal species. [3] [4] [5] The rRNA locus, the most common target for molecular identification, consists of the following regions: small subunit (SSU) 18S rRNA, 5.8S rRNA, large subunit (LSU) 28S rRNA, and internal transcribed regions 1 and 2 (ITS1 and 2). 6 Most molecular detection/identification assays have been focused on the ITS 1-2 and the 5 end of the 28S gene (i.e., D1-D2 region of 28S) [7] [8] [9] [10] [11] ; furthermore, the ITS region has been proposed as a universal barcode marker for fungi. 12 However, in mucormycetes, ITS and D1-D2 regions are not always amenable to amplification and direct sequencing as they sometimes contain large introns, heterogenic regions and/or poly A/T regions, which prevent PCR amplification and/or interfere with sequencing. 10 In addition, these regions can reach 800 bp in size, which make them undesirable for direct DNA detection. 10, 13 Our previous studies suggest that DNA fragments that are less than 300 bp in length can be more efficiently PCR amplified from patient specimens compared to larger fragments. 14, 15 Previously, Khot et al. devel- oped an array of PCR primers targeting various regions of the rRNA locus and demonstrated that several small regions within the 28S rRNA gene can be potentially useful for species identification in fungi; however, these regions have not been evaluated using a broad spectrum of clinically relevant fungi. 6 Here, we explore the utility of 12F/13R PCR primers, which amplify a 200-230 base pair fragment from the center of the 28SrDNA, for detection and identification of mucormycetes and other fungal pathogens. We assess the specificity of this region for genus level identification by conducting a phylogenetic analysis of the DNA sequences from 132 fungi and evaluate the performance of these primers for detection of fungal DNA in 38 tissues.
Materials and methods

Isolates
We evaluated 69 isolates representing nine different medically important genera of mucormycetes from three culture collections (Mycotic Diseases Branch, CDC, National Center for Agricultural Utilization Research, US Department of Agriculture, Peoria, IL, and Centraalbureau voor Schimmelcultures (CBS), The Netherlands) as well as 63 other clinically relevant fungi including 59 Ascomycetes and 4 Cryptococcus isolates (Tables 1-2) .
Sources of fresh and formalin fixed paraffin embedded (FFPE) tissue samples
Human tissue specimens for this investigation (N = 38) were submitted to the CDC Infectious Disease Pathology Branch (IDPB) or the Mycotic Diseases Branch (MDB) as either routine reference laboratory submissions or as part of outbreak investigations. Twenty-one FFPE samples were from routine reference laboratory submissions to MDB, nine were from an outbreak of Apophysomyces following a tornado, 2 and three were from a fungal meningitis outbreak of Exserohilum. 16 In addition, five fresh tissues were received by the IDPB following either skin biopsies (n = 2) or autopsies (n = 3). Twenty-eight tissues were from confirmed cases of fungal infections from which either fungal culture was available (n = 10) or there was histopathological evidence of fungal infections as determined by IDPB (n = 18) as described. 17, 18 Ten cases were either negative by histopathology (n = 4) or had no histopathology performed (n = 6); these cases were suspected to have a fungal infection by the submitting laboratories.
DNA extraction from isolates
The frozen cultures were subcultured on Sabouraud dextrose agar plates and incubated at 37 • C. Genomic DNA was extracted from cultures as previously described using Qiagen DNeasy Blood and Tissue kit (Qiagen, Valencia, CA).
18,19
DNA extraction from fresh tissues
Five fresh tissues (small samples as well as pellets from the centrifugation of tubes containing tissue fragments in saline) were processed as previously described using a QIAamp DNeasy blood and tissue kit (Qiagen) according to the manufacturer's instructions with modification. 18 In brief: (i) Specimens were resuspended in 180 μl of Lyticase Z buffer and incubated with 20 μl of proteinase K at 55
• C for at least 1 h until tissue was digested.
(ii) After digestion with proteinase K, samples were incubated with 0.2 U of Lyticase (MP Biochemicals, Solon, OH) in 1 ml of Z buffer for 1 h at 33
• C with constant agitation. (iii) After digestion with Lyticase, each sample was mixed with one tube of Bashing Beads from ZR Fungal/Bacterial DNA mini kit (Zymo Research Corp., Irvine, CA) and vortexed at high speed for 5 min, after which the suspension was centrifuged at 18,000 g for 15 min, and the supernatant was used for DNA purification.
DNA extraction from FFPE
Nucleic acids were extracted using QIAamp DNA FFPE Tissue Kit (QiagenValencia, CA) following the manufacturer's instructions with three modifications as described earlier. 20 In brief, after incubation and washing with xylene and ethanol, the tube was incubated at room temperature for 1 h. The pellet was digested for 2 h with ATL buffer (Qiagen) and proteinase K at 56
• C. After proteinase K treatment, the pellet was incubated with recombinant Lyticase (L4276; Sigma-Aldrich Corporation, St. Louis, MO; 2 U per 100 μl of solution) for 45 min at 37
• C.
DNA extraction controls
Sterile water samples were processed simultaneously when processing FFPE and fresh tissues and subjected to the same procedures as clinical specimens to control for possible contamination during the extraction procedures; these water samples were later used in PCR as negative controls for contamination.
PCR amplification
PCR primers and sequences are shown in Table 3 ; 12F/13R primers were used for amplification of the extended 28S rDNA, ITS3/ITS4 were used for amplification of ITS2 and D1/D2 were used for amplifications of the 5 end of the 28S (D1-D2 hyper variable region). For PCR with DNA purified from FFPE or fresh tissues, three different DNA dilutions were used (undiluted, 1:2, and 1:10 DNA in sterile water) and those that produced robust PCR products were sequenced. PCR amplification was performed with 1 μl of isolate DNA and 2.5 μl of tissue DNA as the template in a total reaction mixture volume of 25 μl containing 10× PCR buffer (20 mM TrisHCl (pH 8.4), 50 mM KCl); 0.2 mM each dATP, dGTP, dCTP, and dTTP; 1.2 mM MgCl 2 ; 0.2 pmol of each primer; 1U Taq DNA polymerase (Roche Diagnostics, Indianapolis, IN). PCR was carried out in a Gene Amp PCR 9700 thermal cycler (Applied Biosystems, Inc.), Foster City, CA), and the cycling conditions were performed as previously described 15 with PCR primers in Table 3 . PCR products were analyzed by gel electrophoresis, and products were purified using Exo SAP (Affymetrix, Santa Clara, CA) according to the manufacturer's instructions. Twenty microliters sequencing reactions were prepared with 2 μl of DNA template and 3.2 pmol of the same primers used for PCR, 2 μl of Big Dye Terminator v3.1, and 2 μl of sequencing buffer (Applied Biosystems, Inc.) according to the manufacturer's instructions. Extension products were purified using CentriSep plates (Princeton Separations, Inc., Adelphia, NJ) and 
Data analyses
Sequences were generated from both DNA strands and edited manually. Because of the substantial genetic differences between mucormycetes and nonmucormycetes fungi, which interfered with the alignment, the two groups were analyzed separately. For each group, the sequences were aligned using ClustalW with the default parameters in MEGA 6.06 (i.e., gap opening penalty 15, gap extension penalty 6.6). 21 Genetic relationships among isolates were inferred using maximum likelihood (ML) method and the best-fit models of nucleotide substitutions were identified using Bayesian Information criterion (BIC) test implemented in MEGA 6.06. For mucormycetes, Kimura 2-parameter model of nucleotide substitution with gamma correction for different rates among sites (K2+G) was used, while for nonmucormycetes, Tamura-Nei model of nucleotide substitutions with gamma correction (TN93 +G) was used. 21 Alignment gaps were treated as partial deletions. Statistical significance of phylogenetic clades was tested using bootstrap analysis with 1000 reiterations.
Data interpretation
Unknown DNA sequences PCR-amplified from tissues using ITS and D1/D2 PCR primers were identified by comparison to known sequences in NCBI GenBank using the BLAST algorithm using Nucleotide collection database (nr/nt) and Megablast search parameters. Sequences were considered equivalent if they shared at least 98% identity with known sequences. 22 Unknown sequences PCR-amplified from tissues using 12F/13R were identified by aligning with sequences generated using curated isolates from the CDC Mycotic Diseases reference isolate collection and building a phylogenetic tree. Extended 28S rDNA sequences were considered belonging to a specific genus/species if they clustered with the other genera/species on the phylogenetic tree and if that clade was supported by >70% bootstrap value. All isolate sequences from this study were deposited into NCBI GenBank under accession numbers KU561693-KU561738 (Table 1 ) and KU561808-KU561798 (Table 2) .
Results
Performance of 12F and 13R primers for PCR and direct sequencing
Appropriate 200-230 bp PCR products from the extended 28S rRNA region were obtained from all 69 tested isolates of mucormycetes (Table 1 ) and 63 isolates of other fungi ( Table 2 ). All products were subjected to direct sequencing, and unambiguous DNA sequences were generated. Conversely, no PCR products were generated with ITS specific primers from all tested isolates of Apophysomyces trapeziformis. Furthermore, NRRL 6436 isolate of Extended 28S region provides sufficient discriminatory power for genus identification
All genera of mucormycetes as well as Rhizopus stolonifer were clearly separated and well supported by bootstrap analysis using maximum likelihood method (Fig. 1) . With one notable exception of Talaromyces marneffei, whose extended 28S rDNA region was indistinguishable from those of other Penicillium spp., all other clinically relevant genera of filamentous ascomycetes were well separated and supported on the phylogenetic tree (Fig. 2) . The genus Aspergillus was split into several clades, which are consistent with the polyphyletic structure of this taxon (Fig. 2 ). 23 Specifically, the A. terreus clade was well separated and distinguished from other aspergilli on the phylogenetic tree, which is clinically important considering this species' resistance to amphotericin B. Similarly, all major genera of fungi with yeast-like morphology, such as Histoplasma, Cryptococcus and Candida sp., as well as C. glabrata and C. krusei clades were well supported and separated on the tree (Fig. 2) .
Utility of 12F -13R primers for detection of fungi in fresh and FFPE tissues
To compare performances of 12F/13R, ITS 3/4 and D1/D2 PCR primers for detection of fungal DNA in tissues, we tested DNA extracted from 38 tissue samples from proven or suspected cases of fungal infections (Table 4) : a fungal target was amplified from 22 tissues with ITS 3/4 primers, from 13 tissues with D1-D2 primers, and from all 38 tissues with 12F-13R primers. PCR products were sequenced and identified by aligning to sequences from our isolate collection (Figs 1 and 2) . Notably, 12F-13R primers were able to identify fungal DNA from eight specimens from which neither ITS 3/4 nor D1-D2 PCR primers were able to generate products. For 26 of 30 (87%) specimens from which fungal DNA was PCR amplified and sequenced with more than one primer pair, the same identification was obtained with all tested PCR primers, while in three specimens (10%), different species were identified using ITS 3-4 and 12F-13R primers (Table 4 ). In addition, for no. 73798 tissue sample, Pichia sp. was identified using ITS3/4 PCR primers, while C. krusei was identified using 12F/13R primers, which was likely caused by the low quality of ITS3/4 sequence that resulted in ambiguous identification (Table 4 , Fig. 2 ). 
Discussion
Compared to culture and morphologic identification, PCR amplification and sequencing of the rRNA locus provides a rapid and often specific method for fungal identification in tissue specimens, which can be critical for timely and accurate treatment initiation. However, DNA extracted from formalin-fixed tissue specimens is often highly fragmented by degradation from host nucleases and/or depurination due to formalin treatment and, therefore, is not amenable to amplification by the broad spectrum PCR primers targeting ITS and D1-D2 regions, which amplify regions up to 800 bp in size. Furthermore, in some fungi, these broad spectrum PCR primers simply fail to amplify any target. It has been demonstrated that DNA fragments less than 300 bp in size are more likely to be PCR-amplified and detected in FFPE tissue samples 14, 15 . Here, we describe the utility of the 200-230 bp region of the 28S rDNA for direct detection of fungal DNA in both fresh and fixed tissue specimens and identification of fungal genera, using the 12F-13R primer set. We demonstrate that this fragment provides sufficient discriminatory power to identify all genera and some species of clinically relevant mucormycetes as well as tested ascomycetes and the basidiomycete Cryptococcus.
The extended 200-230 bp region of 28S rDNA provides a good target for DNA detection for a number of reasons. First, robust PCR products were obtained from all tested strains of mucormycetes, ascomycetes and Cryptococcus sp. (which is the most clinically relevant genus of basidiomycetes). All PCR products were amenable to direct DNA sequencing and generated high-quality unambiguous reads. Conversely, any combination of ITS 3, 4, and 5 primers consistently failed to generate PCR products from all tested isolates of Apophysomyces trapeziformis and one isolate of Cunninghamella bertholletiae. Second, phylogenetic analyses of the extended 28S rDNA sequences of 69 mucormycetes generated a well-resolved phylogeny with well supported branches corresponding to the commonly defined genera of mucormycetes. Similarly, a well-resolved and supported phylogeny was obtained for 63 isolates of ascomycetes and cryptococci. The only pathogenic fungus of the panel tested that could not be reliably identified by sequencing of the extended 28S rDNA was T. marneffei as its sequence was indistinguishable from those of nonpathogenic Penicillium spp.
We used 12F/13R PCR primers for PCR amplification and sequencing of fungal DNA from tissues of patients with proven or suspected fungal infections and demonstrated that the extended 28S rDNA region can be successfully amplified and used for fungal identification. Specifically, PCR products and unambiguous DNA reads were obtained for all 38 tested tissues using 12F/13R PCR primers, while only 23 tissues were PCR amplified with ITS3/4 and 13 with D1/D2 PCR primers (Table 4 ). For 26 of 30 (87%) tissues for which PCR products were obtained with several PCR primer pairs, the same species identification was obtained using ITS, D1/D2 and the extended 28S rDNA regions. However, for three specimens conflicting results were obtained using ITS and 12F/13R primers, probably due to contamination during handling and processing tissue samples and the high sensitivity of these PCR primers that enabled them to detect extremely low quantities of DNA. Furthermore, for eight tissue samples with histopathological and/or culture evidence of fungal infection, PCR products and DNA sequences were obtained only with the 12F/13R primers, while ITS and D1/D2 specific primers failed to produce an amplification product, which was likely due to the increased sensitivity of 12F/13R primers rather than inability of ITS 3/4 and D1/D2 primers to bind to their targets, because both of ITS 3/4 and D1/D2 primers were able to amplify genomic DNA from the same species (data not shown). The DNA sequencing results from these tissues were consistent with histopathological and/or culture results for these samples (i.e., amplifying a mould when hyphae were seen and amplifying a yeast when yeast cells were seen) (Table 4) .
We recognize the following limitations of our study. First, the extended 28S rDNA region can often only provide identification to the genus level, which makes it less desirable for epidemiological studies and outbreak investigations. However, for the vast majority of fungi, identification to the species level is not required for determination of optimal treatment. Specifically, one of the most important questions that clinicians need to address when treating suspected fungal infection is whether this infection is caused by mucormycetes, Fusarium sp., Aspergillus sp., or other fungi. PCR amplification and sequencing of the extended 28S rDNA can rapidly provide this answer. However, identification to the species level may be important for treating Aspergillus and several other fungi, as different species of these fungi have different antifungal susceptibility patterns. While some species of Aspergillus, such as A. terreus can be identified with these PCR primers, others, such as A. lentulus cannot be differentiated, and additional testing may be required. Second, the quality and reliability of identification can be significantly impeded by the scarcity of extended 28S rDNA sequences in publicly available sequence databases. Although all sequences from our study were deposited into NCBI, the overall poor representation of the extended 28S rDNA regions in databases can result in erroneous identification, as 100% match to a single sequence in a database may not always indicate a unique match, since other yet unsequenced fungi may also have 100% match to this region. This issue may be particularly important for identification of ascomycetes and basidiomycetes, since only a small number of species/isolates are represented. As the numbers of sequenced human pathogenic fungi increase, the representation of 28S rDNA regions in databases will also increase, resulting in more accurate identifications. Finally, similar to all other PCR-based methods, this method of fungal identification is highly prone to contamination. 3, 14, 24 Specifically, three of 28 tissues (10%) evaluated in this study generated inconsistent results when tested with ITS-specific PCR primers. However, this result was not surprising considering the extremely high sensitivity of PCR detection 24, 25 and the ubiquitous presence of fungi in the environment. Others observed comparable misidentification rates when using PCR-based detection methods for clinical specimens with low abundance of fungal DNA. 5, 14, 24, [26] [27] [28] Exceptional care should be taken to avoid contamination during handling and processing tissue and DNA samples and appropriate negative extraction controls should be used at all times. 22 However, reagent impurity, contamination during sample collection from skin flora and/or environment, as well as cross-contamination during DNA extraction and processing cannot be completely avoided; therefore, amplification of fungal DNA from a biological sample does not always imply infection. Therefore, PCR results should be considered in concert with clinical, histopathological, and epidemiological data and should not provide the sole basis for antifungal treatment initiation. Overall, our results provide the proof of principle that the extended region of 28S rDNA can provide a useful target for direct detection and identification of mucormycetes and several other fungal pathogens from human tissue specimens. This region is especially useful for fungi for which universal barcode primers targeting ITS fail to amplify, as well as for direct detection/identification of fungi in FFPE tissue samples, which are likely to contain degraded DNA and for which amplifying a shorter product can be beneficial. However, in order for this region to become useful for routine identification, additional sequencing is needed to assess diversity among other clinically important fungi.
